obesity

https://www.healio.com/news/endocrinology/20230412/testosterone-therapy-may-benefit-men-with-diabetes-and-obesity-but-remains-controversial An increasing number of studies are reporting that testosterone therapy may not only normalize testosterone levels for men but may also provide...

A Systematic Review of Studies Assessing Efficacy and Cardiovascular Safety of Testosterone Replacement Therapy in Men with Late‑onset Hypogonadism Due to Obesity ± Type 2 Diabetes Mellitus (2023) Vinod Abichandani, Atul Kalhan Background: There is a lack of consensus regarding the efficacy...

Has anyone done a DEXA scan before and during use of any GLP-1 agonists (semaglutide, tizepatide) to assess body composition? In Peter Attia's recent blog, he eludes to the fact the GLP-1 agonists can cause loss of lean mass (in addition to fat loss), of particular concern in non-obese persons...

I live in Oklahoma, have been struggling with weight my whole life. My wife and her friends are all on semaglutide and have lost an enormous amount of weight. My insurance doesn’t cover it. Do y’all know of any weight loss clinics that can get me the generic version for cheap?

"Children as young as 12 with obesity should now consider taking weight-loss drugs, and those as young as 13 with severe obesity should consider metabolic or bariatric surgery, according to aggressive new guidelines released Monday by the American Academy of Pediatrics."...

Once-Weekly Semaglutide in Adolescents with Obesity (2022) Daniel Weghuber, M.D., Timothy Barrett, Ph.D., Margarita Barrientos-Pérez, M.D., Inge Gies, Ph.D., Dan Hesse, Ph.D., Ole K. Jeppesen, M.Sc., Aaron S. Kelly, Ph.D., Lucy D. Mastrandrea, M.D., Rasmus Sørrig, Ph.D., and Silva Arslanian...

Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022 Harold E. Bays, Angela Fitch, Sandra Christensen, Karli Burridge, Justin Tondt ABSTRACT Background: This “Anti-Obesity Medications and Investigational Agents: An...

The metabolic role of prolactin: systematic review, meta-analysis and preclinical considerations (2022) Giovanni Corona, Giulia Rastrelli, Paolo Comeglio, Federica Guaraldi, Diego Mazzatena, Alessandra Sforza , Linda Vignozzib and Mario Maggi ABSTRACT Introduction: Hyperprolactinemia has...

Tirzepatide is a new class of medication for t2d that activates GIP and glp1 receptors. Endocrinologist Dr. Thomas Blevins (MD, FACE) from Texas Diabetes and Endocrinology, Austin, TX, presents data and practical information for clinicians.

Tirzepatide is a new class of medication for t2d that activates GIP and glp1 receptors. Endocrinologist Dr. Thomas Blevins (MD, FACE) from Texas Diabetes and Endocrinology, Austin, TX, presents data and practical information for clinicians.

CCRM Fertility's Dr. Brian Levine had the chance to sit down with Dr. Robert Mordkin, Dr. Peter Schlegel, and Registered Dietician & Nutritionist Amy Shapiro to talk about all things men's health. Key Moments * Peter Schlegel *Effects of Obesity *Fertility *Is Fertility a Big Problem...

The data shows that men's testosterone levels have decreased over time. Obesity, stress, and phytoestrogens are partly to blame. Listen as Dr. Abe Morgentaler explains some of the potential reasons for this trend.

Once-Weekly Semaglutide for Weight Management: A Clinical Review (2022) Abby Fornes, PharmD, Jamie Huff, PharmD, BCACP, BC-ADM, Roger Iain Pritchard, PharmD, BCACP, and Miranda Godfrey Abstract Objective: To review the efficacy, safety, and role of the glucagon-like peptide-1 (GLP-1)...

Here are the key points from the video titled "Once-Weekly Tirzepatide for Obesity | NEJM": Study Objective: The trial investigated the effectiveness of the type 2 diabetes drug, tirzepatide, in inducing weight reduction in adults with obesity or overweight plus a weight-related complication...

Tirzepatide Once Weekly for the Treatment of Obesity (2022) Ania M. Jastreboff, M.D., Ph.D., Louis J. Aronne, M.D., Nadia N. Ahmad, M.D., M.P.H., Sean Wharton, M.D., Pharm.D., Lisa Connery, M.D., Breno Alves, M.D., Arihiro Kiyosue, M.D., Ph.D., Shuyu Zhang, M.S., Bing Liu, Ph.D., Mathijs C...

PCRI's resident moderator, Mark Moyad, MD, MPH, asks Dr. Mark Scholz about his experience "semaglutide," a medication used to facilitate weight loss. He asks if it is really the game-changer it is hyped up to be and how it compares to weight loss medications that have been used in the past and...

Martin Miner, MD, is the co-director of the Men’s Health Center at The Miriam Hospital in Providence, Rhode Island, and a clinical professor of family medicine and urology at Brown University. Here, PCRI's resident moderator, Mark Moyad, MD, MPH, asks Dr. Miner about "semaglutide," a medication...

Obesity, type 2 diabetes, and testosterone in ageing men (2022) Gary Wittert · Mathis Grossmann Abstract In the absence of obesity, adverse lifestyle behaviours, and use of medication such as opioids serum testosterone concentrations decrease by only a minimal amount at least until very...

Does any compounding pharmacy offer semaglutide?

We know when it comes to losing weight and keeping it off, genetics make it more difficult for some people, but when we told you about a new medication, called a weight loss game-changer, not everyone could get it. $$$

A transcript of this podcast and more information about Tom Wadden is available on the website of the Duke World Food Policy Center at https://wfpc.sanford.duke.edu/podcast... Much attention has been paid recently in both scientific circles and in the media to a drug for weight loss newly...

http://www.buffalo.edu/news/releases/2022/02/011.html Findings underscore the threat that obesity poses to the health and fertility of young men BUFFALO, N.Y. — A new study led by University at Buffalo researchers shows that bariatric surgery not only treats obesity and reverses Type 2...

The is the longest term study of testosterone therapy (TTh) I've seen. The full text of the study is available online. The summary says: "Our findings demonstrate that in subpopulations of men in different weight categories at baseline, long-term TTh produced significant weight loss while...

The Long Haul: Treating Men with Obesity with Testosterone BY DEREK BAGLEY JUN 2019 A study presented at ENDO 2019 shows that long-term testosterone therapy in men with obesity and hypogonadism can actually contribute to prolonged weight loss without an added risk for mortality or major...

A study duscussed at the Endo 2019 conference showed significant long term weight loss in men treated with testosterone therapy. While it's preferable to lose weight through diet and exercise, the long term success rate for thes changes are low. So having a pharmacological treatment which...

A retrospective observational study of 411 obese hypogonadal men found that testosterone undecanoate injections significantly decreased weight and waist circumference. The conclusion of the study says: "Testosterone therapy appears to be an effective approach to achieve sustained WL [weight...

Hello, This is a rather long post so please bear with me. I'm a 28yo male with a long time history of hypogonadism symptoms, but since I'm overweight I had thought that it all had to do with losing weight. 2 years before I got married I started to feel a heavy loss in libido and some ED. Sadly...

"On their own, most individuals are rarely able to lose a substantial amount of body weight and keep it off. Although record numbers of U.S. adults have an elevated BMI, more than 80% of respondents with overweight or obesity told a 2013 Gallup Poll that they had lost a large amount of weight at...